Valeritas insulin delivery device gets a name

By Katrina Megget

- Last updated on GMT

Related tags: Diabetes, Us

US-based Valeritas has announced the brand name for its lead
candidate disposable insulin delivery device - V-Go.

The medical technology company's device is the first to use the h-Patch technology platform which utilises a small adhesive machine-like patch to deliver both basal and bolus insulin dosages. "We are excited to introduce V-Go as the name for our lead product, and are working to make it available for patients with diabetes in the coming year,"​ Valeritas marketing and marketing operations vice president Tara Charvat said. "V-Go was designed to mimic the physiologic distribution of insulin in a simple fashion, and we believe it has the potential to create a new standard for insulin delivery and improve patient care." ​ V-Go is a once-daily, disposable, waterproof device that provides a continuous set basal rate and on-demand bolus dosing for meal-time coverage, via a rapid acting insulin analogue, for people suffering from Type II diabetes. The patch device works by peeling a protective layer from an adhesive backing on the device and applying it to the body such as around the abdomen area. With the push of the start button, a micro-needle is inserted into the skin and supplies a basal flow of insulin. During mealtimes, the patient pushes the bolus button and a bolus dosing is administered. On removal of the device, the micro-needle retracts, limiting the needle injury risk. Developed to help enhance a patient's glycemic control and improve compliance, V-Go is the smallest known US Food and Drug Administration-cleared insulin delivery device with basal and bolus capability and no visible needle. V-Go is currently in Phase IV clinical trials to support broad marketing and reimbursement claims. The h-Patch technology is hoped to be used for the delivery of a variety of other medicinal compounds other than insulin. Other drug delivery devices Valeritas is developing include: the e-Patch Controlled Release Disposable Micro Pump System, a micro-infusion system designed to deliver drugs continuously into subcutaneous tissue; the Mini-Jet Pre-Filled Needle-Free Delivery System, a next-generation needle-free injection system; and the Micro-Trans Microneedle Transdermal Delivery Patch.

Related topics: Ingredients, Delivery technologies

Related news

Show more

Related products

show more

From Candidate to Clinic- European Capabilities

From Candidate to Clinic- European Capabilities

Catalent Pharma Solutions | 22-Oct-2018 | Technical / White Paper

Catalent’s Nottingham, UK facility focuses on early stage development of small molecule drug candidates from the bench to clinic. This facility offers...

Fill Release at the Right Time in the Right Place

Fill Release at the Right Time in the Right Place

Gelita AG | 19-Sep-2018 | Technical / White Paper

From rapid release in the stomach for e.g. analgesics to enteric release for fills with unpleasant aftertaste – GELITA delivers the respective gelatine...

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

Related suppliers

Follow us

Products

View more

Webinars